[caption id="attachment_3143" align="alignnone" width="620"]
Ping An Healthcare and Technology operates the mobile app "Good Doctor," which provides online healthcare services.[/caption] Clifford Chance and Davis Polk & Wardwell had the lead roles advising Chinese medical technology company Ping An Healthcare and Technology Co. Ltd. on its $1.1 billion initial public offering on the Hong Kong Stock Exchange. Shanghai-based Ping An Healthcare and Technology, a spinoff from Ping An Insurance Co. Ltd., operates the mobile app "Good Doctor" and provides online health care services that include consultation and the dispensing of medicine. The company said in a prospectus that its nationwide network includes 3,100 hospitals and 7,500 dispensaries. Clifford Chance partners Amy Lo and Fang Liu in Hong Kong and Tim Wang in Beijing led a team representing Ping An Healthcare and Technology. Haiwen & Partners Shanghai partners Hu Ji and Zheng Yan acted as Chinese counsel to the issuer. Davis Polk Hong Kong partners Bonnie Chan and Li He advised Citigroup Global Markets Asia and JPMorgan Securities as sponsors. Grandall Law Firm Shanghai partners Yue Yongping and Da Jian served as Chinese counsel to the banks. DLA Piper Shanghai partner Roy Chan and Hong Kong partner Christina Loh acted for Ping An Insurance as controlling shareholder on the listing. Ping An Healthcare and Technology, valued at $7.5 billion, is expected to be the first of many tech unicorns heading toward Hong Kong this year following the change of listing rules in favor of tech companies. Smartphone maker Xiaomi Corp. filed its Hong Kong IPO application last week and is expected to raise at least $10 billion.